Delcath Systems, Inc. (NASDAQ:DCTH) Presents Data of its CHEMOSAT System Presents at CIRSE Annual Meeting as Shares Advance

Delcath Systems, Inc. (NASDAQ:DCTH) Presents Data of its CHEMOSAT System Presents at CIRSE Annual Meeting as Shares Advance

Interventional oncology company focused on the treatment of primary and metastatic liver cancers, Delcath Systems, Inc. (NASDAQ:DCTH) announces the release of data for its CHEMOSTAT system as shares advance over 23% NEW YORK, Sept. 19, 2017 (GLOBE NEWSWIRE) — Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the results of a single institution study were presented at the […]

Read More ˃